Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pentavalent meningococcal conjugate vaccine A C Y W 135 X - PATH/Serum Institute of India

Drug Profile

Pentavalent meningococcal conjugate vaccine A C Y W 135 X - PATH/Serum Institute of India

Alternative Names: MenACYWX; MenFive; Meningococcal vaccine groups A,C,W-135, Y, X conjugate - PATH; Meningococcal-ACYWX-conjugate-vaccine; NmCV-5; Pentavalent-meningococcal-conjugate-vaccine-A-C-Y-W-135-X; Polyvalent meningitis vaccine - PATH; SIIPL Meningococcal ACYWX Conjugate Vaccine; Thermostable pentavalent conjugate meningococcal vaccine - PATH

Latest Information Update: 22 Sep 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator PATH; Serum Institute of India
  • Class Conjugate vaccines; Meningococcal vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Meningococcal infections

Most Recent Events

  • 18 Sep 2023 Primordial Genetics has merged with Pelican Expression Technology to form Primrose Bio
  • 12 Jul 2023 Pentavalent meningococcal conjugate vaccine A C Y W 135 X achieves World Health Organization (WHO) prequalification for Meningococcal infections (Prevention) in Africa
  • 29 Oct 2021 Emory University and National Institute of Allergy and Infectious Diseases plans a phase III trial for Meningococcal infections (Prevention, In children, In infants) in Mali in February 2022 (NCT05093829)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top